Dharti Proteins closes trading window ahead of Q2FY27 results
- Trading window closed from October 1, 2026
- Restriction applies until 48 hours after Q2FY27 results
- Covers Directors, Promoters, and Specified Connected Persons
- Compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015

*this image is generated using AI for illustrative purposes only.
Dharti Proteins Limited closed its trading window for equity shares starting October 1, 2026. The restriction applies to all Directors, Promoters, Designated Persons, and Specified Connected Persons. This closure remains in effect until 48 hours after the company declares its unaudited financial results for the quarter and half-year ending September 30, 2026.
The decision complies with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and the company's internal code of conduct. These regulations mandate that insiders refrain from dealing in securities during periods when price-sensitive information is unpublished. The trading window will reopen once the results are publicly announced and the mandatory cooling-off period expires.
Regulatory compliance and scope
The intimation was filed with BSE Limited on September 23, 2026. The company identified specific categories of personnel bound by this restriction. All designated persons and their immediate relatives are advised not to trade in the securities of Dharti Proteins during the closure period.
| Detail | Information |
|---|---|
| Company | Dharti Proteins Limited |
| Window Closure Start | October 1, 2026 |
| Window Closure End | 48 hours post-results |
| Reporting Period | Q2FY27 (Quarter/Half-year ending Sep 30, 2026) |
| Regulatory Basis | SEBI (PIT) Regulations, 2015 |
The company noted that the date of the Board Meeting for considering and approving these financial results will be communicated in due course. Until then, the prohibition on trading stands firm to ensure market integrity and prevent potential misuse of unpublished price-sensitive information.
When will Dharti Proteins announce the specific date for the Board Meeting to approve the Q2FY27 financial results?
How might the upcoming unaudited results for the quarter ending September 30, 2026, impact investor sentiment and stock volatility upon release?
Are there any pending regulatory filings or material events expected from Dharti Proteins before the trading window reopens?

































